Proteintech Group ptglab.com


Public lists: Pharma Startups (4732)

Proteintech Group is engaged in the design, development and marketing of antibody and antibody-chips in the bioresearch field.

Proteintech Group is engaged in the design, development and marketing of antibody and antibody-chips in the bioresearch field.

Company (Alive / Active)

Phone:

Fax:

2201 West Campbell Park Dr Ste 12

Chicago, 60612
Illinois, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Proteintech Group $0M Nov 30, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Proteintech Group Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Five Prime Therapeutics

South San Francisco, California, United States
IPO / Went publicFive Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discovery capabilities built on its library of secreted and extracellular human proteins, which it leverages in cell-based assays, in vivo models and receptor-ligand matching screens to identify medically relevant new targets and therapeutic proteins. FivePrime has entered into a collaboration agreement to...Show allLogin to see details

Caprion Pharmaceuticals

Montreal, Quebec, Canada
MergedCaprion's leading and proteomics discovery technologies - CellCarta - enable the discovery of targets for therapeutics development and the identification of protein biomarkers that can reduce risk and enhance clinical development productivity and decision making in Pharmaceutical research. In March 2007, Caprion Pharmaceuticals merged with Ecopia BioSciences to form Thallion Pharmaceuticals.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)